PANGENOMIC HEALTH INC. Financials Pangenomic Health Inc.
Equities
NARA
CA69842E3041
Advanced Medical Equipment & Technology
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.08 CAD | 0.00% |
|
0.00% | -60.00% |
| Feb. 19 | PanGenomic Health plans to withdraw shares from Aquis Stock Exchange | AN |
| Feb. 16 | Pangenomic Health Inc. Announces Changes to Board of Directors | CI |
Valuation
| Fiscal Period: December | 2022 |
|---|---|
| Capitalization 1 | 19.99 |
| Enterprise Value (EV) 1 | 20 |
| P/E ratio | -1.23 x |
| Yield | - |
| Capitalization / Revenue | - |
| EV / Revenue | - |
| EV / EBITDA | -5,609,164 x |
| EV / FCF | -14,230,361 x |
| FCF Yield | -0% |
| Price to Book | -118 x |
| Nbr of stocks (in thousands) | 7,403 |
| Reference price 2 | 2.700 |
| Announcement Date | 5/1/23 |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Net sales | - | - | - | - |
| EBITDA | - | - | -0.8475 | -3.566 |
| EBIT 1 | -0.000072 | -0.1349 | -0.8496 | -3.577 |
| Operating Margin | - | - | - | - |
| Earnings before Tax (EBT) 1 | -0.003438 | -0.14 | -2.649 | -11.99 |
| Net income 1 | -0.003438 | -0.14 | -2.649 | -11.99 |
| Net margin | - | - | - | - |
| EPS 2 | -0.005857 | -0.2385 | -1.339 | -2.189 |
| Free Cash Flow | - | -0.0864 | -0.4715 | -1.406 |
| FCF margin | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 3/28/22 | 3/28/22 | 5/1/23 | 5/1/23 |
1CAD in Million2CAD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Net Debt 1 | - | - | - | 0.01 |
| Net Cash position 1 | 0 | 0.01 | 1.35 | - |
| Leverage (Debt/EBITDA) | - | - | - | -0.003714 x |
| Free Cash Flow | - | -0.09 | -0.47 | -1.41 |
| ROE (net income / shareholders' equity) | - | -2,091% | -235% | -1,183% |
| ROA (Net income/ Total Assets) | - | -110% | -39% | -145% |
| Assets 1 | - | 0.1269 | 6.796 | 8.265 |
| Book Value Per Share 2 | 0 | 0.0200 | 0.4900 | -0.0200 |
| Cash Flow per Share 2 | 0 | 0.0700 | 0.3800 | 0.0100 |
| Capex | - | - | 0.01 | 0.01 |
| Capex / Sales | - | - | - | - |
| Announcement Date | 3/28/22 | 3/28/22 | 5/1/23 | 5/1/23 |
1CAD in Million2CAD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -60.00% | 615K | |
| +4.24% | 32.58B | |
| +16.26% | 7.65B | |
| +21.60% | 3.92B | |
| -15.50% | 3.19B | |
| -27.13% | 1.26B | |
| -31.01% | 1.14B | |
| -34.81% | 926M | |
| +0.87% | 908M | |
| -24.69% | 859M |
- Stock Market
- Equities
- NARA Stock
- Financials Pangenomic Health Inc.
